Rockwell Medical (NASDAQ:RMTI) Upgraded by RODMAN&RENSHAW to “Strong-Buy” Rating

RODMAN&RENSHAW upgraded shares of Rockwell Medical (NASDAQ:RMTI) to a strong-buy rating in a research report released on Thursday morning,Zacks.com reports.

RMTI has been the subject of several other research reports. StockNews.com upgraded Rockwell Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, November 13th. Rodman & Renshaw assumed coverage on Rockwell Medical in a research note on Thursday. They issued a “buy” rating and a $5.00 price target for the company. Finally, HC Wainwright reiterated a “buy” rating and set a $9.00 price objective on shares of Rockwell Medical in a research report on Wednesday, September 11th.

Rockwell Medical Trading Down 5.2 %

Shares of Rockwell Medical stock opened at $2.36 on Thursday. Rockwell Medical has a fifty-two week low of $1.16 and a fifty-two week high of $5.15. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.60 and a current ratio of 2.41. The company has a market capitalization of $76.28 million, a P/E ratio of -47.10 and a beta of 1.50. The company has a fifty day moving average of $3.68 and a 200 day moving average of $2.62.

Hedge Funds Weigh In On Rockwell Medical

Several institutional investors have recently added to or reduced their stakes in RMTI. Barclays PLC purchased a new stake in shares of Rockwell Medical during the 3rd quarter worth approximately $90,000. XTX Topco Ltd raised its stake in Rockwell Medical by 45.7% during the third quarter. XTX Topco Ltd now owns 28,455 shares of the company’s stock valued at $113,000 after purchasing an additional 8,922 shares in the last quarter. Jane Street Group LLC bought a new position in Rockwell Medical during the third quarter valued at $534,000. State Street Corp lifted its position in Rockwell Medical by 21.5% during the third quarter. State Street Corp now owns 95,004 shares of the company’s stock valued at $377,000 after purchasing an additional 16,800 shares during the last quarter. Finally, HighTower Advisors LLC grew its stake in shares of Rockwell Medical by 75.6% in the 3rd quarter. HighTower Advisors LLC now owns 57,413 shares of the company’s stock worth $228,000 after buying an additional 24,715 shares in the last quarter. Hedge funds and other institutional investors own 23.31% of the company’s stock.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.